Gluten Intolerance in The Wall Street Journal
On March 15, The Wall Street Journal published an article that discusses the complexity, yet growing prevalence of gluten sensitivities. Health Journal columnist Melinda Beck explains that the medical community has begun to acknowledge the existence of gluten intolerance in a new light. A recent study released by BMJ Medicine posits that gluten can cause a negative immune response even for those who have tested negative for Celiac Disease. This news will surely be embraced by patients who suffer from these gluten sensitivities but often do not receive the necessary support from their doctors.
While the study presents important advances in the field, more research is needed on this subject as many questions remain unanswered. For instance, Dr. Alessio Fasano, medical director of the University of Maryland’s Center for Celiac Research and lead author of the study, eventually wants to ascertain a biomarker specifically for gluten intolerance.
In the meantime, the pervasiveness of Celiac Disease, gluten sensitivity and wheat allergy brings a greater awareness of such conditions. So, even though Peter Green, director of the Celiac Disease Center, remarks that the research on gluten sensitivities is where the research on Celiac Disease was 30 years ago, hopefully, with this increased awareness, the necessary research will yield desired results at a quicker pace.
As of now, for those who experience negative reactions to gluten, the best treatment is following a gluten free diet. And, as the article mentions, this treatment is becoming less daunting since the gluten free foods market continues to grow.
Do you suffer from gluten intolerance? If so, what have your experiences been in regards to the medical community? And, how do you think this new study will affect the gluten free community?